For media inquiries, please contact:
Stephanie Dunn, Manager, Research Communications | 604-875-2401

Click on a tag to sort the news stories by theme:

$4.3-million grant to CFRI-led national childhood cancer research team

April 11, 2012
Share this:

The federal government announced today $4.3 million in funding to a national childhood cancer research team led by principal investigator Dr. Kirk Schultz. The team will assess biomarkers to identify children at risk of adverse effects of cancer treatments and to predict potential long-term complications. Studies will focus on biomarkers associated with hearing loss, kidney failure, blood clotting problems, and a type of tissue rejection called chronic graft-versus host disease that can occur after bone marrow transplantation. The studies include eight child health centres across Canada. The team is called Applying Biomarkers to Long-term Effects in Child and Adolescent Cancer Treatment (ABLE Team) and the team's co-principal investigators include CFRI investigators Professor Mary McBride and Dr. Rod Rassekh.

[Canadian Institutes of Health Research (CIHR) news release]  
[CIHR fact sheet]
[CBC story]